关注
Wang-Zhong Li
Wang-Zhong Li
First Affiliated Hospital of Guangzhou Medical University
在 gzhmu.edu.cn 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Development and validation of an endoscopic images‐based deep learning model for detection with nasopharyngeal malignancies
C Li, B Jing, L Ke, B Li, W Xia, C He, C Qian, C Zhao, H Mai, M Chen, ...
Cancer Communications 38 (1), 1-11, 2018
702018
Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III–IVB nasopharyngeal carcinoma …
X Lv, X Cao, WX Xia, KY Liu, MY Qiang, L Guo, CN Qian, KJ Cao, HY Mo, ...
The Lancet Oncology 22 (5), 716-726, 2021
552021
Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis
C An, WZ Li, ZM Huang, XL Yu, YZ Han, FY Liu, SS Wu, J Yu, P Liang, ...
European Radiology 31, 4764-4773, 2021
442021
The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling
WZ Qiu, HB Zhang, WX Xia, LR Ke, J Yang, YH Yu, H Liang, XJ Huang, ...
Journal of Experimental & Clinical Cancer Research 37, 1-17, 2018
402018
The prognostic significance of carcinoma-associated fibroblasts and tumor-associated macrophages in nasopharyngeal carcinoma
Y Yu, L Ke, X Lv, YH Ling, J Lu, H Liang, W Qiu, X Huang, G Liu, W Li, ...
Cancer Management and Research, 1935-1946, 2018
402018
Deep learning radiomics of dual-energy computed tomography for predicting lymph node metastases of pancreatic ductal adenocarcinoma
C An, D Li, S Li, W Li, T Tong, L Liu, D Jiang, L Jiang, G Ruan, N Hai, Y Fu, ...
European journal of nuclear medicine and molecular imaging, 1-13, 2022
382022
Development of a prognostic model to identify the suitable definitive radiation therapy candidates in de novo metastatic nasopharyngeal carcinoma: a real-world study
WZ Li, SH Lv, GY Liu, H Liang, X Guo, X Lv, KY Liu, MY Qiang, X Chen, ...
International Journal of Radiation Oncology* Biology* Physics 109 (1), 120-130, 2021
342021
Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score …
GY Liu, X Lv, YS Wu, MJ Mao, YF Ye, YH Yu, H Liang, J Yang, LR Ke, ...
Cancer Communications 38 (1), 1-10, 2018
302018
Immune checkpoint inhibitor associated hepatotoxicity in primary liver cancer versus other cancers: a systematic review and meta‐analysis
J Fu, WZ Li, NA McGrath, CW Lai, G Brar, YQ Xiang, C Xie
Frontiers in oncology 11, 650292, 2021
292021
Effect of capecitabine maintenance therapy plus best supportive care vs best supportive care alone on progression-free survival among patients with newly diagnosed metastatic …
GY Liu, WZ Li, DS Wang, H Liang, X Lv, YF Ye, C Zhao, LR Ke, SH Lv, ...
JAMA oncology 8 (4), 553-561, 2022
282022
Effect of induction chemotherapy with paclitaxel, cisplatin, and capecitabine vs cisplatin and fluorouracil on failure-free survival for patients with stage IVA to IVB …
WZ Li, X Lv, D Hu, SH Lv, GY Liu, H Liang, YF Ye, W Yang, HX Zhang, ...
JAMA oncology 8 (5), 706-714, 2022
272022
Age-dependent changes of gender disparities in nasopharyngeal carcinoma survival
WZ Li, SH Lv, GY Liu, H Liang, WX Xia, YQ Xiang
Biology of sex Differences 12, 1-10, 2021
212021
Assessment of survival model performance following inclusion of Epstein-Barr virus DNA status in conventional TNM staging groups in Epstein-Barr virus–related nasopharyngeal …
WZ Li, HJ Wu, SH Lv, XF Hu, H Liang, GY Liu, N Lu, WX Bei, X Lv, X Guo, ...
JAMA network Open 4 (9), e2124721-e2124721, 2021
212021
A randomized controlled trial comparing two different schedules for cisplatin treatment in patients with locoregionally advanced nasopharyngeal cancer
WX Xia, X Lv, H Liang, GY Liu, R Sun, Q Zeng, SW Li, HY Mo, F Han, ...
Clinical cancer research 27 (15), 4186-4194, 2021
202021
The plasma Epstein–Barr virus DNA level guides precision treatment for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a large population-based cohort …
HU Liang, X Lv, L Wang, YS Wu, R Sun, YF Ye, LR Ke, Q Yang, YH Yu, ...
Therapeutic Advances in Medical Oncology 10, 1758835918782331, 2018
192018
A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapy
WZ Qiu, LR Ke, WX Xia, J Yang, YH Yu, H Liang, XJ Huang, GY Liu, WZ Li, ...
PLoS One 12 (8), e0182963, 2017
192017
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease …
M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ...
The Lancet 403 (10440), 2162-2203, 2024
162024
MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy …
WZ Li, GY Liu, LF Lin, SH Lv, MY Qiang, X Lv, YS Wu, H Liang, LR Ke, ...
Radiotherapy and Oncology 145, 101-108, 2020
152020
Benefit of chemotherapy in stage III nasopharyngeal carcinoma: analysis of the surveillance, epidemiology, and end results database
ZF Xiang, DF Hu, HC Xiong, MY Li, ZC Zhang, ED Shen, WZ Li, YQ Xiang
Oral Oncology 117, 105284, 2021
132021
A scoring system based on nutritional and inflammatory parameters to predict the efficacy of first-line chemotherapy and survival outcomes for de novo metastatic nasopharyngeal …
WZ Li, X Hua, SH Lv, H Liang, GY Liu, N Lu, WX Bei, WX Xia, YQ Xiang
Journal of Inflammation Research, 817-828, 2021
132021
系统目前无法执行此操作,请稍后再试。
文章 1–20